+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2025-2030- Product Image
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2025-2030- Product Image
Sale

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127172
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence (AI) and advanced computational tools are fundamentally reshaping peptide drug discovery, empowering organizations to expedite candidate identification, streamline lead selection, and enable more personalized, precise therapeutics than ever before. This landscape is a catalyst for innovation, delivering substantial advantages in efficiency and collaboration to pharmaceutical and biotechnology stakeholders.

Market Snapshot: AI-Driven Peptide Drug Discovery

Recent advances in machine learning algorithms, structural modeling, and high-throughput screening technologies have combined to unlock a new era in peptide drug discovery. Leveraging vast biological datasets with predictive analytics, researchers can now identify candidate peptides with enhanced specificity and potency at an unprecedented pace. This integration of computational tools into molecular biology not only accelerates target validation and optimizes lead generation, but also significantly reduces the time and resources traditionally necessary for early drug development. The growing interest in peptide-based modalities spans cardiovascular, metabolic, infectious, neurological, and oncological applications, signaling a surge in demand for AI-driven peptide drug discovery platforms.

Scope & Segmentation of the Peptide Drug Discovery Market

  • Technology Type: Cloud-based platforms (public, private, hybrid), deep learning frameworks (convolutional, recurrent, graph neural networks), machine learning (reinforcement, supervised, unsupervised methods), on-premise high-performance computing, and dedicated servers
  • Therapeutic Application: Cardiovascular (including atherosclerosis and heart failure), infectious diseases (bacterial and viral pathogens), metabolic disorders (such as diabetes and obesity), neurological indications (Alzheimer’s, Parkinson’s), and oncology (hematological malignancies and solid tumors)
  • End User: Academic and government research institutes, contract research organizations (large and small), pharmaceutical and biotechnology companies
  • Peptide Class: Cyclic (head-to-tail and side chain cyclization), linear peptides (long and short chain), peptidomimetics (beta-peptides, peptoids)
  • Workflow Stage: Target identification (genomics, proteomics), lead generation (high-throughput and in silico screening), preclinical validation (in vitro, in vivo), clinical development (Phases I-III)
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe (UK, Germany, France, Russia, Italy, Spain, etc.), Middle East & Africa (UAE, Saudi Arabia, South Africa, etc.), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia)

Key Takeaways for Decision-Makers

  • Integration of deep learning, reinforcement learning, and generative algorithms is accelerating peptide candidate selection, reducing traditional bottlenecks in early-stage development.
  • Cloud-based and on-premise deployments offer secure, scalable processing for massive genomics and proteomics workloads, supporting both established firms and emerging biotechs.
  • Regulatory harmonization and localized validation workflows are enabling cross-border research consortia to advance pipeline productivity in response to regional economic shifts.
  • Organizations are leveraging modular AI architectures to rapidly pivot molecular design priorities and expand into new therapeutic areas without major redevelopment.
  • Academic-industry partnerships and CRO collaborations are expanding access to unique datasets and preclinical capabilities, driving validation and accelerating discovery timelines.

Tariff Impact on Supply Chains and Collaborations

The introduction of new United States tariffs in 2025 has raised costs for peptide drug discovery by increasing duties on critical reagents, enzymes, and synthesis equipment. Developers are mitigating these impacts by diversifying procurement, developing new partnerships outside affected regions, and localizing validation processes. As a result, firms are recalibrating R&D strategies to balance cost efficiency with collaborative growth, leading to new innovation clusters and adjusted regional footprints.

Leading Players and Strategic Advances

  • Biotechnology companies are forming alliances with cloud providers to implement scalable AI-driven discovery environments.
  • Start-ups are developing proprietary graph-based modeling to enhance peptide-receptor interaction predictions.
  • Established pharmaceutical leaders are actively integrating AI-based insights through strategic acquisitions and collaborations.
  • Contract research organizations are offering end-to-end solutions encompassing supervised and unsupervised machine learning modules for streamlined lead progression.
  • Academic spin-offs and specialized technology vendors are leveraging proprietary datasets and reinforcement learning to enable novel target discovery and optimized sequence libraries.

Methodology & Data Sources

This report’s analysis is grounded in a rigorous research framework encompassing secondary research from peer-reviewed journals, patent filings, and company sources, supplemented by primary expert interviews. Analytical techniques include statistical modeling and triangulation of multiple data streams for accuracy.

Why This Report Matters

  • Empowers senior decision-makers to benchmark technology adoption, collaboration models, and workflow strategies across key segments of the peptide drug discovery landscape.
  • Highlights actionable pathways to optimize resource allocation, risk mitigation, and cross-sector partnerships in light of regulatory and economic variables.
  • Supports competitive planning by detailing the spectrum of technological, therapeutic, and regional opportunities, tailored for strategic R&D growth.

Conclusion

AI and computational technologies are reshaping peptide drug discovery by enabling rapid, data-driven advancements across scientific, operational, and geographic fronts. Organizations that invest in agile platforms and collaborative innovation will sustain competitive advantage in this evolving field.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Deployment of deep reinforcement learning models to predict peptide 3D conformations and binding kinetics for novel targets
5.2. Integration of AI-driven molecular docking and high throughput screening data to accelerate cyclic peptide lead optimization
5.3. Adoption of generative adversarial networks for designing de novo peptide sequences with enhanced stability and specificity
5.4. Collaborations between biopharma companies and AI startups to deploy cloud-based peptide synthesis prediction workflows for faster candidate validation
5.5. Regulatory agencies evaluating AI validation frameworks to ensure reproducibility and accuracy of peptide drug discovery algorithms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI-driven Peptide Drug Discovery Platform Market, by Technology Type
8.1. Introduction
8.2. Cloud Based Platform
8.2.1. Hybrid Cloud
8.2.2. Private Cloud
8.2.3. Public Cloud
8.3. Deep Learning Platform
8.3.1. Convolutional Neural Network
8.3.2. Graph Neural Network
8.3.3. Recurrent Neural Network
8.4. Machine Learning Platform
8.4.1. Reinforcement Learning
8.4.2. Supervised Learning
8.4.3. Unsupervised Learning
8.5. On Premise Platform
8.5.1. Conventional Hpc
8.5.2. Dedicated Servers
9. AI-driven Peptide Drug Discovery Platform Market, by Therapeutic Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Atherosclerosis
9.2.2. Heart Failure
9.3. Infectious Diseases
9.3.1. Bacterial
9.3.2. Viral
9.4. Metabolic Disorders
9.4.1. Diabetes
9.4.2. Obesity
9.5. Neurological
9.5.1. Alzheimers
9.5.2. Parkinsons
9.6. Oncology
9.6.1. Hematological Malignancies
9.6.2. Solid Tumors
10. AI-driven Peptide Drug Discovery Platform Market, by End User
10.1. Introduction
10.2. Academic & Government Research Institutes
10.2.1. Private Research Institutes
10.2.2. Public Research Institutes
10.3. Contract Research Organizations
10.3.1. Large Cro Organizations
10.3.2. Small Cro Organizations
10.4. Pharmaceutical & Biotechnology Companies
10.4.1. Biotechnology Companies
10.4.2. Pharmaceutical Companies
11. AI-driven Peptide Drug Discovery Platform Market, by Peptide Class
11.1. Introduction
11.2. Cyclic Peptides
11.2.1. Head to Tail
11.2.2. Side Chain to Side Chain
11.3. Linear Peptides
11.3.1. Long Peptides
11.3.2. Short Peptides
11.4. Peptidomimetics
11.4.1. Beta Peptides
11.4.2. Peptoids
12. AI-driven Peptide Drug Discovery Platform Market, by Workflow Stage
12.1. Introduction
12.2. Clinical Development
12.2.1. Phase I
12.2.2. Phase II
12.2.3. Phase III
12.3. Lead Generation
12.3.1. High Throughput Screening
12.3.2. In Silico Screening
12.4. Preclinical Validation
12.4.1. In Vitro
12.4.2. In Vivo
12.5. Target Identification
12.5.1. Genomics
12.5.2. Proteomics
13. Americas AI-driven Peptide Drug Discovery Platform Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa AI-driven Peptide Drug Discovery Platform Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Schrödinger, Inc.
16.3.2. Exscientia plc
16.3.3. Insilico Medicine, Inc.
16.3.4. Recursion Pharmaceuticals, Inc.
16.3.5. PeptiDream Inc.
16.3.6. Nuritas Limited
16.3.7. Evaxion Biotech a/S
16.3.8. BioSymetrics, Inc.
16.3.9. BenevolentAI Ltd.
16.3.10. Arctoris Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET: RESEARCHAI
FIGURE 26. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET: RESEARCHSTATISTICS
FIGURE 27. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET: RESEARCHCONTACTS
FIGURE 28. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GRAPH NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GRAPH NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVENTIONAL HPC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVENTIONAL HPC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEDICATED SERVERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEDICATED SERVERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ALZHEIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ALZHEIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PARKINSONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PARKINSONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LARGE CRO ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LARGE CRO ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SMALL CRO ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SMALL CRO ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEAD TO TAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEAD TO TAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SIDE CHAIN TO SIDE CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SIDE CHAIN TO SIDE CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LONG PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LONG PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SHORT PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SHORT PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BETA PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BETA PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LEAD GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LEAD GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY IN SILICO SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY IN SILICO SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LEAD GENERATION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LEAD GENERATION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRECLINICAL VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRECLINICAL VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY IN VITRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY IN VITRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY IN VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY IN VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRECLINICAL VALIDATION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRECLINICAL VALIDATION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY WORKFLOW STAGE, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LEAD GENERATION, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LEAD GENERATION, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRECLINICAL VALIDATION, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRECLINICAL VALIDATION, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2024 (U

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI-driven Peptide Drug Discovery Platform market report include:
  • Schrödinger, Inc.
  • Exscientia plc
  • Insilico Medicine, Inc.
  • Recursion Pharmaceuticals, Inc.
  • PeptiDream Inc.
  • Nuritas Limited
  • Evaxion Biotech A/S
  • BioSymetrics, Inc.
  • BenevolentAI Ltd.
  • Arctoris Limited

Related Topics

Related Reports

mRNA Vaccine Drugs Development Services Market - Global Forecast 2025-2030 - Product Image

mRNA Vaccine Drugs Development Services Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030 - Product Image

Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Drug Discovery Services Market Report 2025 - Product Image

Drug Discovery Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
AI Driven Drug Discovery Patent Landscape Report - Product Image

AI Driven Drug Discovery Patent Landscape Report

  • Report
  • 96 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.